Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting

European Journal of Preventive Cardiology

Volumn 22, Issue 1, 2015, Pages 75-82

  Meyer, Thomas ^a   Hussein, Sharif ^a   Lange, Helmut W ^b   Herrmann Lingen, Christoph ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Cardiological Practice   (Germany)

Author keywords

Anxiety; Coronary heart disease; Mortality; Prognosis

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY STENTING; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PATIENT HISTORY OF CORONARY ARTERY BYPASS GRAFT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; PSYCHOMETRY; STATISTICAL SIGNIFICANCE; SURVIVAL; ADVERSE EFFECTS; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CORONARY DISEASE; DEVICES; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROTECTION; PSYCHOLOGY; RETREATMENT; RISK; RISK ASSESSMENT; RISK FACTOR; STENT; TIME; TREATMENT OUTCOME;

AGED; ANXIETY; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RETREATMENT; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84918523827     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313505244     Document Type: Article

References (32)

1. Schömig A, Mehilli J, de Waha A, et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 894-904.
2. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: A quantitative 20-year synopsis and a network meta-analysis. Lancet 2009; 373: 911-918.
3. Denollet J, Strik JJ, Lousberg R, et al. Recognizing increased risk of depressive comorbidity after myocardial infarction: Looking for 4 symptoms of anxiety-depression. Psychother Psychsom 2006; 75: 346-352.
4. Pajak A, Jankowski P, Kotseva K, et al. EUROASPIRE Study Group. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: The EUROASPIRE III Study. Eur J Prev Cardiol 2013; 20: 331-340.
5. Haines AP, Imeson JD and Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 1987; 295: 297-299.
6. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997.
7. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90: 2225-2229.
8. Frasure-Smith N, Lespérance F and Talajic M. The impact of negative emotions on prognosis following myocardial infarction. Is it more than depression?. Health Psychol 1995; 14: 388-398.
9. Moser DK and Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996; 58: 395-401.
10. Albert CM, Chae CU, Rexrode KM, et al. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480-487.
11. Rothenbacher D, Hahmann H, Wüsten B, et al. Symptoms of anxiety and depression in patients with stable coronary heart disease: Prognostic value and consideration of pathogenetic links. Eur J Cardiovasc Prev Rehabil 2007; 14: 547-554.
12. Moser DK, Riegel B, McKinley S, et al. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med 2007; 69: 10-16.
13. Shibeshi WA, Young-Xu Y and Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol 2007; 49: 2021-2027.
14. Frasure-Smith N and Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008; 65: 62-71.
15. Shen BJ, Avivi YE, Todaro JF, et al. Anxiety characteristics independently and prospectively predict myocardial infarction in men. The unique contribution of anxiety among psychologic factors. J Am Coll Cardiol 2008; 51: 113-119.
16. Denollet J, Maas K, Knottnerus A, et al. Anxiety predicted premature all-cause and cardiovascular death in a 10-year follow-up of middle-aged women. J Clin Epidemiol 2009; 62: 452-456.
17. Roest AM, Martens EJ, Denollet J, et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010; 72: 563-569.
18. Moser DK, McKinley S, Riegel B, et al. Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease. Psychosom Med 2011; 73: 803-809.
19. Pedersen SS, Denollet J, Spindler H, et al. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J Psychosom Res 2006; 61: 783-789.
20. Strik JJ, Denollet J, Lousberg R, et al. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003; 19: 1801-1807.
21. Sullivan MD, LaCroix AZ, Spertus JA, et al. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol 2000; 86: 1135-1138.
22. Bui E, Cailhol L, Puel J, et al. Effects of depressive symptoms, anxiety and alexithymia on physical functioning 6 months after percutaneous transluminal coronary angioplasty. Psychother Psychosom 2010; 79: 59-60.
23. Schmidt MM, Quadros AS, Abelin AP, et al. Psychological characteristics of patients undergoing percutaneous coronary interventions. Arq Bras Cardiol 2011; 97: 331-337.
24. Meyer T, Buss U and Herrmann-Lingen C. Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med 2010; 72: 9-15.
25. Mykletun A, Bjerkeset O, Dewey M, et al. Anxiety, depression, and cause-specific mortality: The HUNT study. Psychosom Med 2007; 69: 323-331.
26. Zigmond AS and Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
27. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
28. Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363-370.
29. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
30. Blumenthal JA, Thompson LW, Williams RB Jr, et al. Anxiety-proneness and coronary heart disease. J Psychosom Res 1979; 23: 17-21.
31. Herrmann C, Brand-Driehorst S, Buss U, et al. Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. J Psychosom Res 2000; 48: 455-462.
32. Poston WS, Haddock CK, Conard MW, et al. Assessing depression in the cardiac patient. When is the appropriate time to assess depression in the patient undergoing coronary revascularization? Behav Modif 2003; 27: 26-36.